LifeMD, Inc.
LFMDNasdaqCIK 948320HealthcareFiscal year ends Dec 31
Reports and events: 225 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2023-03-2221:03 ET | 10-K | Annual reportPeriod 2022-12-31 | 0001493152-23-008560 |
| 2023-02-1022:11 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-23-004330 |
| 2023-02-1001:24 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-23-004172 |
| 2022-12-2120:39 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-22-036130 |
| 2022-11-1413:53 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-22-031678 |
| 2022-11-1022:04 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0001493152-22-031429 |
| 2022-09-2017:16 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-22-026343 |
| 2022-09-1419:42 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001493152-22-025851 |
| 2022-08-1120:46 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0001493152-22-022112 |
| 2022-06-2218:48 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0001493152-22-017477 |
| 2022-05-1313:27 ET | 10-Q | Quarterly reportPeriod 2022-03-31 | 0001493152-22-013198 |
| 2022-04-2914:00 ET | DEF 14A | Proxy statementPeriod 2022-04-29 | 0001493152-22-011492 |
| 2022-03-0721:31 ET | 10-K | Annual reportPeriod 2021-12-31 | 0001493152-22-006182 |
| 2022-02-2219:49 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits | 0001493152-22-005094 |
| 2022-02-2218:15 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-22-005087 |
| 2022-02-0722:27 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-22-003384 |
| 2022-02-0220:51 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-22-002985 |
| 2022-01-1917:26 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-22-001561 |
| 2022-01-1914:37 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-22-001552 |
| 2022-01-1221:56 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-22-001058 |
| 2021-11-1214:15 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001493152-21-028044 |
| 2021-11-1022:01 ET | 10-Q | Quarterly reportPeriod 2021-09-30 | 0001493152-21-027886 |
| 2021-10-0420:49 ET | 8-K | 1.01 Entry into a material agreement; 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-21-024517 |
| 2021-09-2720:43 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-21-023872 |
| 2021-09-2216:39 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-21-023338 |
| 2021-09-1320:42 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-21-022552 |
| 2021-08-1313:34 ET | 10-Q | Quarterly reportPeriod 2021-06-30 | 0001493152-21-019603 |
| 2021-08-0415:10 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-21-018520 |
| 2021-07-2221:18 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-21-017563 |
| 2021-07-1520:32 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-21-016951 |
| 2021-07-0221:20 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001493152-21-016109 |
| 2021-06-2921:22 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0001493152-21-015594 |
| 2021-06-2113:00 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001493152-21-014801 |
| 2021-06-1620:50 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-21-014560 |
| 2021-06-0311:30 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-21-013492 |
| 2021-06-0118:41 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-21-013322 |
| 2021-05-2122:31 ET | S-1/A | Registration statement, amended | 0001493152-21-012392 |
| 2021-05-1916:47 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-21-012202 |
| 2021-05-1417:41 ET | 10-Q | Quarterly reportPeriod 2021-03-31 | 0001493152-21-011449 |
| 2021-05-1320:29 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-21-011307 |
| 2021-05-1220:07 ET | DEF 14A | Proxy statementPeriod 2021-05-12 | 0001493152-21-011130 |
| 2021-04-2821:31 ET | S-1 | Registration statement | 0001493152-21-009969 |
| 2021-04-2315:34 ET | SC 13D | Ownership report, active investor | 0001493152-21-009517 |
| 2021-04-1921:23 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-21-009159 |
| 2021-04-1621:23 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-21-009046 |
| 2021-04-1521:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-21-008952 |
| 2021-04-1510:30 ET | SC 13D/A | Ownership report, active investor, amended | 0001493152-21-008805 |
| 2021-04-0621:21 ET | 8-K | 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-21-008118 |
| 2021-04-0114:40 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-21-007652 |
| 2021-03-3020:47 ET | 10-K | Annual reportPeriod 2020-12-31 | 0001493152-21-007194 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:01 ET. Listed shows no prices and gives no investment advice.